A subscription to JoVE is required to view this content. Sign in or start your free trial.
This study presents a porcine model of pulmonary embolism (PE) using large autologous emboli that replicate acute intermediate-risk PE. The model is well-suited for the evaluation of both pathophysiology and treatment responses.
Acute pulmonary embolism (PE) is a potentially life-threatening condition that causes abrupt obstruction of the pulmonary arteries, leading to acute right heart failure. Novel diagnostic methods and catheter-directed therapies are being developed rapidly, and there is an obvious need for a realistic PE animal model that can be used for pathophysiological evaluation and preclinical testing.
This protocol introduces a porcine model employing large autologous pulmonary emboli. Instrumentations are performed with minimally invasive techniques, creating a close-chest model that enables the investigation of various treatment options with high reproducibility. Three hours after drawing blood to create autologous emboli ex vivo, the induction of PE caused an immediate increase in the mean pulmonary arterial pressure (17 ± 3 mmHg to 33 ± 6 mmHg, p < 0.0001) and heart rate (50 ± 9 beats·min-1 to 63 ± 6 beats·min-1, p < 0.0003) accompanied by a decreased cardiac output (5.0 ± 0.8 L/min to 4.5 ± 0.9 L/min, p < 0.037) compared to baseline. The CT pulmonary angiography revealed multiple emboli, and the pulmonary obstruction percentage was increased compared to baseline (0% [0-0] to 57.1% [38.8-63.3], p < 0.0001). In the acute phase, the phenotype is comparable to intermediate-risk PE.
The model represents a realistic and well-characterized phenotype of intermediate-risk PE and creates an opportunity to test novel diagnostic methods, interventional and pharmaceutical treatments, and hands-on training for healthcare workers in interventional procedures.
Acute pulmonary embolism (PE) is the third most common cause of cardiovascular death and is a manifestation of venous thromboembolism (VTE)1. The incidence of VTE ranges between 75 to 269 per 100,000 population per year and is increasing with age2. Initial survivors face a 30-day risk of death ranging from 0.5 % for low-risk patients and up to 22 % for high-risk patients3. The cause of death is right ventricular (RV) failure, which predominantly happens within hours4,5. Even if patients survive, there is still a risk of significant morbidi....
This study was conducted with approval from the Danish Animal Inspectorate (license no. 2021-15-0201-00944) and in compliance with the Danish and university guidelines on laboratory animal welfare and ethics.
NOTE: This study followed the ARRIVE guidelines 2.017. The principles of the 3Rs (Replacement, Reduction, and Refinement) were respected by evaluating each animal repeatedly to serve as its own control, thereby reducing the number of animals needed and to maximize .......
In a pooled analysis of pigs included in previous studies, we present the results characterizing the acute PE model described in this protocol15,16. Two pigs died from acute right heart failure following PE. In total, we included 24 pigs.
Hemodynamics
The response after each embolus is evident in Figure 5. The induction of PE (5 ± 1) caused an immediate increase in mPAP (17.......
This paper describes a porcine model of acute, intermediate-risk PE using autologous emboli that is minimally invasive and reproducible.
There are some critical steps in this protocol. First, the dilation of the access in the right external jugular vein is crucial for the model as it serves as the access point for the emboli. When advancing the large sheath, it is essential to adhere to the guidance of the stiff wire under continuous fluoroscopy to prevent rupture or dissection of major vessel.......
We wish to express our sincere gratitude for the tremendous dedication and hard work exhibited by the staff at the Department of Clinical Medicine, Aarhus University, in completing the experiments. Furthermore, we want to thank our collaborators at the Department of Forensic Medicine, Aarhus University, and the Department of Radiology, Massachusetts General Hospital, for the invaluable assistance in conducting and analyzing the CT pulmonary angiography. The work has been supported by Aarhus University Graduate School, Karen Elise Jensen's Foundation, Danish Heart Foundation, NIH-grant no. 1R01HL168040-01, Novo Nordisk Foundation [NNF17OC0024868], Holger og Ruth He....
Name | Company | Catalog Number | Comments |
12L-RS | GE Healthcare Japan | 5141337 | Ultrasound probe |
50 mL BD Luer-Lock | BD Plastipak | 300865 | |
Adhesive Aperature Drape (OneMed) | evercare | 1515-01 | 75 cm x 90 cm (hole: 6 cm x 8 cm) |
Alaris GP Guardrails plus | CareFusion | 9002TIG01-G | Infusion pump |
Alaris Infusion set | BD Plastipak | 60593 | |
Alcohol swap | MEDIQ Danmark | 3340012 | 82% ethanol, 0.5% chlorhexidin, skin disinfection |
Amplatz Support Wire Guide Extra-Stiff | Cook Medical | THSF-25-260-AES | diameter: 0.025 inches, length: 260 cm |
Aortic Perfusion Cannula | Edwards Lifesciences | AA024TFTA | Size: 24F. Length: 30 cm. |
BD Connecta | BD | 394601 | Luer-Lock |
BD Emerald | BD | 307736 | 10 mL syringe |
BD Platipak | BD | 300613 | 20 mL syringe |
BD Venflon Pro | Becton Dickinson Infusion Therapy | 393204 | 20 G |
BD Venflon Pro | Becton Dickinson Infusion Therapy | 393208 | 17 G |
Butomidor Vet | Richter Pharma AG | 531943 | 10 mg/mL |
Chlorhexidine 0.5% | Meda AB | N/A | |
Cios Connect S/N 20015 | Siemens Healthineers | N/A | C-arm |
CP Oxygenation System Adult With Fusion and Cardioplegia 1/B | Medtronic | M450311W | Custom cardiopulmonary oxygenation system including a cardioplegia line. |
D-LCC12A-01 | GE Healthcare Finland | N/A | Pressure measurement monitor |
Durapore | 3M | N/A | Adhesive tape |
E-PRESTIN-00 | GE Healthcare Finland | 6152932 | Respirator tubes |
Euthanimal | Alfasan | 136278 | Pentobarbitalnatrium 400 mg/mL (0.5 mL/kg for euthanasia) |
Favorita II | Aesculap | GT104 | |
Fentanyl | B. Braun | 71036 | 50 µg/mL |
Glucose isotonic | SAD | 419358 | 55 mg/mL Isotonic glucose (500 mL bag) |
Gore DrySeal Flex Introducer Sheath | GORE | DSF2633 | Size: 26 French. Working length: 33 cm. |
Ketaminol Vet | MSD/Intervet International B.V. | 511519 | 100 mg/mL |
Lawton 85-0010 ZK1 | Lawton | N/A | Laryngoscope |
Lectospiral | VYGON | 1159.90 | 400 cm (Luer-LOCK) |
MBH qufora | MBH-International A/S | 13853401 | Urine bag |
Natriumchlorid | Fresenius Kabi | 7340022100528 | 9 mg/mL Isotonic saline |
Noradrenalin | Macure Pharma | 425318 | 1 mg/mL |
PICO50 Aterial Blood Sampler | Radiometer | 956-552 | 2 mL |
Portex Tracheal Tube | Smiths Medical | 100/150/075 | Cuffed Clear Oral/Nasal Murphy Eye |
Pressure Extension set | CODAN | 7,14,020 | Tube for anesthetics, 150 cm long, inner diameter 0.9 mm |
Propolipid | Fresenius Kabi | 21636 | Propofol, 10 mg/mL |
Radiofocus Introducer II | Radiofocus/Terumo | RS+B80N10MQ | 7 + 8F sheaths |
Rompun Vet | Beyer | 86450917 | Xylazin, 20 mg/mL |
Rüsch Brilliant AquaFlate Glycerine | Teleflex | 178000 | Bladder catheter, size 14 |
S/5 Avance | Datex-Ohmeda | N/A | Mechanical ventilator |
Safersonic Conti Plus & Safergel | SECMA medical innovation | SAF.612.18120.WG.SEC | 18 cm x 120 cm (Safersonic Sterile Transducer Cover with Adhesive Area and Safergel) |
Standard Dilator | Cook Medical | G01212 | Size: 16 French. Length: 20 cm. |
Swan-Ganz CCOmbo | Edwards Lifesciences | 744F75 | 110 cm |
TruWave Pressure Monitoring Set | Edwards Lifesciences | T434303A | 210 cm |
Vigilance VGS Patient Monitor | Edwards Lifesciences | N/A | |
Vivid iq | GE Medical Systems China | Vivid iq | |
Zoletil 50 Vet (tiletamin 125 mg and zolazepam 125 mg) | Virbac | 83046805 | Zoletil Mix for pigs: 1 vial of Zoletil 50 Vet (dry matter); add 6.25 mL Xylozin (20 mg/mL), 1.25 mL ketamin (100 mg/mL) and 2.5 mL Butorphanol (10 mg/mL). Dose for pre-anesthesia: 0.1 mL/kg as intramuscular injection |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved